[vimeo id=”72415163″ width=”600″ height=”350″]
Increasing your sugar may have a bad effect on your health. Dr. Mayo Friedlis, with National Spine and Pain Centers and StemCell ARTS, joined MYFOX5DC with advice on managing one’s sugar intake and the long-term effect of sugar on one’s joints.
To read more about the actual study that was the subject of this news story, click here
WUSA TV News recently featured Dr. Mayo Friedlis in a segment focused on Stem Cell Therapy for damaged and arthritic joints. The story looks at the return to an active lifestyle of a StemCell ARTS patient who underwent stem cell therapy for knee problems following arthroscopic surgery and physical therapy. Dr. Mayo Friedlis of StemCell ARTS also discusses the Regenexx Stem Cell Procedures and the science behind stem cell therapy.
[youtube id=”_VSag-eyU2c” width=”640″ height=”480″]
Dr Robert Wagner was a featured lecturer on “Stem Cell & Platelet Injections: Can They Help Heal Musculoskeletal Injuries?” at the Annual Sports Medicine Symposium at INOVA Mount Vernon Hospital (June 14, 2013).
Members of the National Athletic Trainers’ Association (NATA) attended along with area athletic trainers, physical therapists and sports medicine-oriented healthcare providers, Dr. Wagner discussed how stem cells and platelets promote better healing of injured tissues, what types of injuries can be effectively treated with stem cell and platelet injections, and outlined which patients are good and bad candidates for Regenerative Medicine techniques. These techniques are performed at Stem Cell Arts (www.stemcellarts.com) in Fairfax, Virginia by Mayo Friedlis, MD, Robert Wagner, MD and Rodney Dade, MD.
Other speakers at the conference included: Seminar 2013 Faculty-Annual Sports Medicine Symposium Program Director, Sameer Nagda, MD, Orthopedic Surgeon, Anderson Orthopaedic Clinic [Assistant Clinical Professor of Orthopaedic Surgery, Georgetown University School of Medicine; Team Physician Potomac Nationals Baseball Team]; George C. Branche, III, MD, Orthopedic Surgeon, Anderson Orthopaedic Clinic [Sports Medicine Consultant, Walter Reed Army, Medical Center; Clinical Preceptor, Physician Assistant Program, The George Washington University; Clinical Assistant Professor, Georgetown University School of Medicine; Consultant, ATP Tennis Tour]; J. Greg Bennett, PT, DSc, MS Adjunct Faculty, Orthopaedics and Sports Rehabilitation, Marymount University School of Physical Therapy; President, Excel Physical Therapy; Wiemi Douoguih, MD Orthopedic Surgeon, Director of Sports Medicine for MedStar Washington Hospital Center, Department of Orthopaedic Surgery; Medical Director – Washington Nationals Baseball Team (MLB); Cassie Gyuricza Root, MD, Orthopedic Surgeon/Hand Specialist Nirschl Orthopaedic Center; Stephen Saddler, MD, Orthopedic Surgeon, Anderson Orthopaedic Clinic; Assistant Clinical Professor of Orthopaedic Surgery, Georgetown University School of Medicine; Medical Director, Potomac Nationals Baseball Team; Robert H. Wagner, MD Pain Management Specialist Expert in PRP and Prolotherapy National Spine & Pain Center; Brent Wiesel, MD, Chief of Shoulder Surgery, Assistant Professor of Orthopaedic Surgery, Department of Orthopaedic Surgery, Georgetown University School of Medicine
Our Dr. Robert Wagner was recently interviewed on WMAL Radio, where he discussed the causes, diagnosis and treatment of common overuse conditions such as tennis elbow, golfer’s elbow and other non-sports related scenarios that lead to painful joints. He also explains some of the common treatments that we use for these conditions, such as Platelet Rich Plasma (PRP) and Prolotherapy.
If you do not see an audio controller above, click here to listen to the interview
BACKGROUND:
Elbow tenderness and pain with resisted wrist extension are common manifestations of lateral epicondylar tendinopathy, also known as tennis elbow. Previous studies have suggested platelet-rich plasma (PRP) to be a safe and effective therapy for tennis elbow.
PURPOSE:
To evaluate the clinical value of tendon needling with PRP in patients with chronic tennis elbow compared with an active control group.
STUDY DESIGN:
Randomized controlled trial; Level of evidence, 2.
METHODS:
A total of 230 patients with chronic lateral epicondylar tendinopathy were treated at 12 centers over 5 years. All patients had at least 3 months of symptoms and had failed conventional therapy. There were no differences in patients randomized to receive PRP (n = 116) or active controls (n = 114). The PRP was prepared from venous whole blood at the point of care and contained both concentrated platelets and leukocytes. After receiving a local anesthetic, all patients had their extensor tendons needled with or without PRP. Patients and investigators remained blinded to the treatment group throughout the study. A successful outcome was defined as 25% or greater improvement on the visual analog scale for pain.
RESULTS:
Patient outcomes were followed for up to 24 weeks. At 12 weeks (n = 192), the PRP-treated patients reported an improvement of 55.1% in their pain scores compared with 47.4% in the active control group (P = .163). At 24 weeks (n = 119), the PRP-treated patients reported an improvement of 71.5% in their pain scores compared with 56.1% in the control group (P = .019). The percentage of patients reporting significant elbow tenderness at 12 weeks was 37.4% in the PRP group versus 48.4% in the control group (P = .143). Success rates for patients at 12 weeks were 75.2% in the PRP group versus 65.9% in the control group (P = .104). At 24 weeks, 29.1% of the PRP-treated patients reported significant elbow tenderness versus 54.0% in the control group (P = .009). Success rates for patients with 24 weeks of follow-up were 83.9% in the PRP group compared with 68.3% in the control group (P = .037). No significant complications occurred in either group.
CONCLUSION:
No significant differences were found at 12 weeks in this study. At 24 weeks, however, clinically meaningful improvements were found in patients treated with leukocyte-enriched PRP compared with an active control group.
Am J Sports Med. 2014 Feb;42(2):463-71. doi: 10.1177/0363546513494359. Epub 2013 Jul 3.
If the regenerative treatment options offered by StemCell ARTS are not right for you, National Spine and Pain Centers provide more traditional treatments for spine and joint conditions.